Mind Well being Digital Platform to be out there in Might 2023
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a man-made intelligence-driven digital well being firm specializing in enhancing mind well being, immediately publicizes that it’s going to incorporate OpenAI’s expertise, ChatGPT, in its BRAIN AGE™ Synthetic Intelligence (“AI”) Product Suite, which already contains a wide range of API interfaces to construct AI and machine studying features, to additional improve the Firm’s novel Mind Well being Digital Platform to evaluate general mind well being and presence of cognitive impairment in athletes, and people recognized with a psychological well being and neurodegenerative situation.
DiagnaMed’s Mind Well being Digital Platform includes a number of evaluation instruments generated quickly by self-report or clinician-observed measures, every capturing totally different points of mind well being to guage general mind well being, output a affected person danger rating, and supply actionable factors to develop precision medicine-like, personalised therapy plans and interventions. As a part of the BRAIN AGE™ AI Product Suite, the Mind Well being Platform can even embrace distinctive mind coaching, video games, schooling, and training purposes. The Firm expects to launch the Mind Well being Digital Platform as a normal scientific instrument in Might 2023.
“Our Brain Health Digital Platform, which is part of our BRAIN AGE™ AI product suite, offers licensed professionals a novel brain health assessment tool, patient risk score, and helpful intervention plans and techniques, incorporating OpentAI’s technology, ChatGPT, with the aim to improve brain health and brain age of patients,” mentioned Fabio Chianelli, Chairman of DiagnaMed. “We expect to launch the Brain Health Digital Platform in the U.S. and Canada in Q2-2023 for use in sports, mental health and neurology clinics that are committed to improving the brain health of over 50 million people with mental health and neurological disorders.”
About DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. (CSE: DMED) is a man-made intelligence-driven digital well being firm specializing in enhancing mind well being for psychological well being and neurodegenerative problems. The Firm is creating its BRAIN AGE™ AI Product Suite, which incorporates BRAIN AGE™, an electroencephalogram-based (EEG) synthetic intelligence answer to detect a person’s mind age, and the Mind Well being Digital Platform for scientific and residential use. Study extra at DiagnaMed.com.
For extra details about DiagnaMed, please contact:
Fabio Chianelli
Chairman of the Board
DiagnaMed Holdings Corp.
Tel: 416-800-2684
Electronic mail: data@diagnamed.com
Web site: www.diagnamed.com
Neither the Canadian Securities Alternate nor its Regulation Providers Supplier have reviewed or settle for duty for the adequacy or accuracy of this launch.
Cautionary Assertion
Sure statements on this information launch are forward-looking statements, together with with respect to future plans, and different issues. Ahead-looking statements include statements that aren’t purely historic, together with any statements concerning beliefs, plans, expectations or intentions concerning the longer term. Such info can usually be recognized by means of forwarding-looking wording equivalent to “may”, “expect”, “estimate”, “anticipate”, “intend”, “believe” and “continue” or the damaging thereof or comparable variations. The reader is cautioned that assumptions used within the preparation of any forward-looking info could show to be incorrect. Occasions or circumstances could trigger precise outcomes to vary materially from these predicted, on account of quite a few recognized and unknown dangers, uncertainties, and different components, a lot of that are past the management of the Firm, together with however not restricted to, enterprise, financial and capital market situations, the power to handle working bills, and dependence on key personnel. Such statements and knowledge are based mostly on quite a few assumptions concerning current and future enterprise methods and the surroundings wherein the Firm will function sooner or later, anticipated prices, and the power to realize targets. Components that would trigger the precise outcomes to vary materially from these in forward-looking statements embrace, the continued availability of capital and financing, litigation, failure of counterparties to carry out their contractual obligations, lack of key workers and consultants, and normal financial, market or enterprise situations. Components that would trigger precise outcomes to vary materially from these anticipated in these forward-looking statements are described underneath the caption “Risk Factors” in DiagnaMed’s closing prospectus dated October 26, 2022, which is obtainable on the Firm’s profile at www.sedar.com. Ahead-looking statements contained on this information launch are expressly certified by this cautionary assertion. The reader is cautioned to not place undue reliance on any forward-looking info. The forward-looking statements contained on this information launch are made as of the date of this information launch. Besides as required by legislation, the Firm disclaims any intention and assumes no obligation to replace or revise any forward-looking statements, whether or not on account of new info, future occasions or in any other case.
This information launch doesn’t represent a suggestion to promote or the solicitation of a suggestion to purchase, and shall not represent a suggestion, solicitation or sale in any state, province, territory or jurisdiction wherein such supply, solicitation or sale could be illegal previous to registration or qualification underneath the securities legal guidelines of any such state, province, territory or jurisdiction.
0 Comments